Vertex Pharmaceuticals Incorporated logo VRTX - Vertex Pharmaceuticals Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 48
HOLD 8
SELL 0
STRONG
SELL
0
| PRICE TARGET: $552.80 DETAILS
HIGH: $616.00
LOW: $436.00
MEDIAN: $558.00
CONSENSUS: $552.80
UPSIDE: 27.22%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

B+ 77.5 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — no stock price or analyst input.

Profitability

Weight: 25%
C- 50.1
  • 5yr Avg ROIC 12.5% 72/100
  • Operating Margin Trend -4.50 pp/yr 0/100
Contributes 12.5 pts toward composite.

Capital Efficiency

Weight: 15%
B 72.7
  • 5yr Avg ROE 13.6% 75/100
  • 5yr Share-Count CAGR -0.2% 68/100
Contributes 10.9 pts toward composite.

Growth Quality

Weight: 25%
A 88.8
  • 5yr Revenue CAGR 12.4% 86/100
  • 5yr EPS CAGR 14.2% 86/100
  • Revenue-Growth Years (5) 5/5 100/100
Contributes 22.2 pts toward composite.

Cash Generation

Weight: 20%
A+ 96.7
  • 5yr FCF Margin 25.7% 96/100
  • 5yr FCF/NI Conversion 0.98x 98/100
Contributes 19.3 pts toward composite.

Balance Sheet

Weight: 10%
A+ 99.0
  • Net Debt / EBITDA -0.55x 98/100
  • Interest Coverage (EBIT/Int) 357.95x 100/100
  • Altman Z-Score 11.51 100/100
Contributes 9.9 pts toward composite.

Stability

Weight: 5%
C 54.6
  • EPS Volatility (σ/μ) 0.52 29/100
  • Piotroski F-Score 5 56/100
  • Negative-Revenue Years (5) 0/5 100/100
Contributes 2.7 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 4 gurus held; 1 added; 3 trimmed.

Holders
4
Avg Δ position
+137.1%
New buys
0
Full exits
0
As of Q1 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Piotroski F-Score, Negative-Revenue Years (5)

We deliberately ignore stock price, analyst targets, and consensus ratings so the grade is suitable for backtesting forward returns. A minimum of 5 fiscal years of audited statements is required; distressed and highly leveraged infrastructure businesses are declared ungradable rather than forced into a numeric score.